What is Eton Pharmaceuticals, Inc.'s revenue?

Eton Pharmaceuticals, Inc. (ETON) generated $86.9M in revenue over the trailing twelve months, up 79.9% year over year.

Is Eton Pharmaceuticals, Inc. profitable?

Eton Pharmaceuticals, Inc. is not currently profitable: it reported a net loss of $4.5M over the trailing twelve months, a -9.5% net margin.

What are Eton Pharmaceuticals, Inc.'s profit margins?

Gross margin is 54.8% and operating margin is -15.1%, with a -9.5% net margin.

What is Eton Pharmaceuticals, Inc.'s earnings per share?

Eton Pharmaceuticals, Inc.'s diluted EPS over the trailing twelve months is $-0.06.

Where does Eton Pharmaceuticals, Inc.'s income statement data come from?

Every line is extracted from Eton Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Eton Pharmaceuticals, Inc. ETON Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$86.93M+79.9%	$79.95M+105%	$70.32M+103%	$58.18M+85.4%	$48.33M+40.9%
Total cost of revenue	$39.32M+96.0%	$37.21M+139%	$34.2M+142%	$23.62M+85.7%	$20.06M+73.2%
Gross profit	$47.61M+68.5%	$42.74M+82.6%	$36.12M+75.6%	$34.56M+85.2%	$28.27M+24.4%
Gross margin	54.8%-3.7pp	53.5%-6.6pp	51.4%-7.9pp	59.4%-0.1pp	58.5%-7.8pp
Research and development	$8.48M—	$7.77M—	——	——	——
General and administrative	$37.1M+38.6%	$35.82M+57.4%	$33.68M+63.4%	$30.86M+57.0%	$26.77M+42.8%
Other operating expenses	$45.57M+49.3%	$43.58M+67.6%	$38.8M+50.5%	$35.37M+41.8%	$30.53M+37.7%
Total operating expenses	$45.57M+49.3%	$43.58M+67.6%	$38.8M+50.5%	$35.37M+41.8%	$30.53M+37.7%
Operating income	——	——	——	——	——
Interest expense	——	——	——	——	——
Income before income taxes	——	——	-$6.48M-22.2%	-$4.03M+36.9%	-$4.5M-488%
Income tax expense	——	——	$199K+13.7%	$101K-66.4%	$89K-64.0%
Net income	——	——	-$6.68M-21.9%	-$4.13M+38.3%	-$4.58M-602%
Diluted earnings per share	——	——	——	——	——
Basic earnings per share	——	——	-$0.26-18.2%	-$0.17+34.6%	-$0.19-575%
Weighted-average shares, diluted	——	——	——	——	——
Weighted-average shares, basic	108M+3.4%	107.6M+4.1%	106.6M+3.4%	105.6M+2.6%	104.5M+1.7%
Interest Income (Expense), Nonoperating	——	——	——	——	——
Revenue From Contract With Customer Excluding Assessed Tax	$86.93M+79.9%	$79.95M+105%	$70.32M+103%	$58.18M+85.4%	$48.33M+40.9%
EBIT	——	——	-$3.82M+26.8%	-$1.95M+69.0%	-$3.41M-729%
EBITDA	——	——	-$437K+89.3%	$704K+113%	-$1.48M-201%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Eton Pharmaceuticals, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Eton Pharmaceuticals, Inc.'s revenue?: Eton Pharmaceuticals, Inc. (ETON) generated $86.9M in revenue over the trailing twelve months, up 79.9% year over year.
Is Eton Pharmaceuticals, Inc. profitable?: Eton Pharmaceuticals, Inc. is not currently profitable: it reported a net loss of $4.5M over the trailing twelve months, a -9.5% net margin.
What are Eton Pharmaceuticals, Inc.'s profit margins?: Gross margin is 54.8% and operating margin is -15.1%, with a -9.5% net margin.
What is Eton Pharmaceuticals, Inc.'s earnings per share?: Eton Pharmaceuticals, Inc.'s diluted EPS over the trailing twelve months is $-0.06.
Where does Eton Pharmaceuticals, Inc.'s income statement data come from?: Every line is extracted from Eton Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.